Nurse Practitioner, Gerontology · Houston, TX
NPI
1821746835
Since 2022
Specialty
Nurse Practitioner, Gerontology
Code 363LG0600X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1515 Holcombe Blvd
Houston, TX, 77030
Phone (713) 792-6161
Groups this clinician bills Medicare through
Medicare paid, 2024
$6,730
106 services
Medicare patients, 2024
50
Average age 71
Drug cost, 2024
$3.7M
491 prescriptions
Company payments, 2025
$567
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rosalie L Sicalag was code 99214 (office e&m - established), 81 times for 39 patients. In total Rosalie L Sicalag billed 106 services in 6 codes, and Medicare paid $6,730.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-09-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 81 | 39 | $60.20 | $4,877 |
| 99214 Office E&M - Established | Office | 17 | 11 | $74.98 | $1,275 |
By year: 2022 $3,644 for 55 services; 2023 $7,407 for 120 services; 2024 $6,730 for 106 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rosalie L Sicalag prescribed most often to Medicare patients was Cabometyx (Cabozantinib S-Malate), with 61 prescriptions and refills. In total Rosalie L Sicalag wrote 491 Medicare prescriptions that cost $3.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Cabometyx Cabozantinib S-Malate | 61 | 61 | Under 11 | $1.5M |
| Welireg Belzutifan | 57 | 57 | Under 11 | $1.3M |
| Levothyroxine Sodium Generic | 51 | 91 | 16 | $363 |
| Prednisone Generic | 30 | 40 | 13 | $124 |
| Sps Sodium Polystyrene Sulfon/Sorb | 17 | 17 | Under 11 | $3,690 |
| Pantoprazole Sodium Generic | 17 | 23 | Under 11 | $160 |
| Metoprolol Tartrate Generic | 14 | 18 | Under 11 | $30.56 |
| Ondansetron Odt Ondansetron | 14 | 14 | Under 11 | $355 |
| Nifedipine Er Nifedipine | 13 | 27 | Under 11 | $243 |
| Lenvima Lenvatinib Mesylate | 13 | 13 | Under 11 | $303K |
| Inlyta Axitinib | 12 | 12 | Under 11 | $275K |
| Hydrocortisone Generic | 12 | 12 | Under 11 | $223 |
| Promethazine Hcl Generic | 11 | 11 | Under 11 | $82.44 |
| Omeprazole Generic | 11 | 11 | Under 11 | $99.77 |
Brand drugs: 201 claims; generic drugs: 290 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rosalie L Sicalag $567 ($567 in general payments such as food, travel and fees) from 6 companies. The largest payer was Exelixis Inc. with $334.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.